Showing results (81-90 of 139) with videos related to
Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2023
Prevalence of Potentially Clinically Significant Drug-Drug Interactions With Antiretrovirals Against HIV Over Three Decades: A Systematic Review of the LiteratureDaryl Hodge, Eva Maria Hodel, Elen Hughes, et al.Clinical Pharmacokinetics|October 30, 2020
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIVPerrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.The Journal of Antimicrobial Chemotherapy|October 31, 2025
Piperacillin dosing in pediatric patients and augmented renal clearance: are current guidelines sufficient to achieve therapeutic concentration coverage?Anne Ravix, Ermindo Roberto Di Paolo, Kim Dao, et al.The Journal of Antimicrobial Chemotherapy|January 17, 2025
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysisDavid Haefliger, Lynn Mina, Monia Guidi, et al.Journal of Mass Spectrometry : JMS|March 12, 2020
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIVPerrine Courlet, Susana Alves Saldanha, Matthias Cavassini, et al.Molecular Endocrinology (Baltimore, Md.)|May 24, 2007
A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expressionCatia Marzolini, Rommel G Tirona, Guillermo Gervasini, et al.Clinical Pharmacology and Therapeutics|May 14, 2022
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and ComedicationsCatia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.The Journal of Antimicrobial Chemotherapy|September 30, 2022
Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort StudyKaroline Aebi-Popp, Christian R Kahlert, Pierre-Alex Crisinel, et al.Hepatology (Baltimore, Md.)|February 14, 2020
New Drugs for NASH and HIV Infection: Great Expectations for a Great NeedGiovanni Guaraldi, James B Maurice, Catia Marzolini, et al.Chemotherapy|November 7, 2024
Importance of Sex-Dependent Differences for Dosing Selection and Optimization of Chemotherapeutic DrugsClaire Seydoux, Myriam Briki, Anna D Wagner, et al.Pageof 14